Genes in panel
STRs in panel
Prev Next

Structural eye disease

Gene: B3GALNT2

Green List (high evidence)

B3GALNT2 (beta-1,3-N-acetylgalactosaminyltransferase 2)
EnsemblGeneIds (GRCh38): ENSG00000162885
EnsemblGeneIds (GRCh37): ENSG00000162885
OMIM: 610194, Gene2Phenotype
B3GALNT2 is in 18 panels

2 reviews

Nicola Ragge (Birmingham Women's and Children's NHS Foundation Hospital Trust)

Green List (high evidence)

Stevens reported seven cases with muscular dystrophy with eye and brain anomalies with homozygous or compound heterozygous variants in B3GALNT2, two of these cases had microphthalmia and another two had optic nerve hypoplasia. Zebrafish model had retinal degeneration
Created: 2 Oct 2019, 3:48 p.m. | Last Modified: 2 Oct 2019, 3:48 p.m.
Panel Version: 0.91

Publications

Variants in this GENE are reported as part of current diagnostic practice

Mariya Moosajee (Moorfields Eye Hospital)

Green List (high evidence)

Phenotypes
Muscular Dystrophy-Dystroglycanopathy, Type A, 11,

History Filter Activity

1 Oct 2019, Gel status: 3

Added New Source, Added New Source, Set publications, Status Update

Ivone Leong (Genomics England Curator)

Source Expert Review Green was added to B3GALNT2. Source NHS GMS was added to B3GALNT2. Publications for gene B3GALNT2 were changed from to 23453667 Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

16 Sep 2019, Gel status: 2

Entity classified by Genomics England curator

Ivone Leong (Genomics England Curator)

Gene: b3galnt2 has been classified as Amber List (Moderate Evidence).

23 Apr 2019, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Ivone Leong (Genomics England Curator)

gene: B3GALNT2 was added gene: B3GALNT2 was added to Structural eye disease. Sources: London North GLH Mode of inheritance for gene: B3GALNT2 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: B3GALNT2 were set to Muscular Dystrophy-Dystroglycanopathy, Type A, 11, 615181